{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:58:15Z","timestamp":1784602695855,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Italian Ministry of Health (IZS AM 03\/22 RC dal titolo \"OneCoV: coronavirus animali emergenti e impatto nella Salute Pubblica) the project MEDNET."},{"name":"Directorate of International Cooperation, Principaut\u00e9 de Monaco"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Primary Immunodeficiency disorders (PID) can increase the risk of severe COVID-19 and prolonged infection. This study investigates the duration of SARS-CoV-2 excretion and the genetic evolution of the virus in pediatric PID patients as compared to immunocompetent (IC) patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>A total of 40 nasopharyngeal and 24 stool samples were obtained from five PID and ten IC children. RNA detection was performed using RT-qPCR, and whole-genome sequencing was conducted with the NexSeq 1000 platform. Data analysis used the nextflow\/viralrecon pipeline. Hotspot amino acid frequencies were investigated using GraphPad Prism v10. Phylodynamic analysis was conducted with BEAST software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In IC children, the viral excretion period lasted up to 14 days in nasopharyngeal swabs, with an average duration of 7 days, and ranged from 7 to 14 days in stool samples. In PID patients, the viral RNA was detected in nasopharyngeal for periods between 7 and 28 days, with an average duration of 15 days, and up to 28 days in stool samples. Two SARS-CoV-2 variants were detected in PID patients: Delta (AY.122) and Omicron (BA.1.1). Patients with antibody and combined deficiencies, exhibited the most prolonged shedding periods in both nasopharyngeal and stool samples and one patient presented complications and fatal outcome. Specific Hotspot amino acid changes were detected in PID: A2821V and R550H (ORF1ab).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our findings underscore the prolonged excretion of SARS-CoV-2 RNA in patients with antibody and combined deficiencies. Thus, specialized care is essential for effectively managing PID patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12985-025-02628-7","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T23:07:47Z","timestamp":1736809667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["SARS-CoV-2 excretion and genetic evolution in nasopharyngeal and stool samples from primary immunodeficiency and immunocompetent pediatric patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Haifa","family":"Khemiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhem","family":"Ben Fraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla","family":"Mekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iolanda","family":"Mangone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariem","family":"Gdoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Di Pasqual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Camm\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Di Lollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Cherni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henda","family":"Touzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Sadraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zina","family":"Meddeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed","family":"Hogga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imen","family":"Ben Mustapha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed-Ridha","family":"Barbouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Ouederni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henda","family":"Triki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sondes","family":"Haddad-Boubaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"issue":"2","key":"2628_CR1","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/ccr3.3643","volume":"9","author":"H Ahanchian","year":"2021","unstructured":"Ahanchian H, Moazzen N, Sezavar M, Khalighi N, Khoshkhui M, Aelami MH, et al. COVID-19 in a child with primary antibody deficiency. Clin Case Rep. 2021;9(2):755\u20138. https:\/\/doi.org\/10.1002\/ccr3.3643.","journal-title":"Clin Case Rep"},{"key":"2628_CR2","doi-asserted-by":"publisher","unstructured":"Mercatelli D, Giorgi FM. Geographic and Genomic Distribution of SARS-CoV-2 Mutations. Front Microbiol. 2020;11. Available at: https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2020.01800. https:\/\/doi.org\/10.3389\/fmicb.2020.01800.","DOI":"10.3389\/fmicb.2020.01800"},{"issue":"6","key":"2628_CR3","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.amjms.2020.07.027","volume":"360","author":"F Babaha","year":"2020","unstructured":"Babaha F, Rezaei N. Primary Immunodeficiency diseases in COVID-19 pandemic: a predisposing or protective factor? Am J Med Sci. 2020;360(6):740\u20131. https:\/\/doi.org\/10.1016\/j.amjms.2020.07.027.","journal-title":"Am J Med Sci"},{"key":"2628_CR4","doi-asserted-by":"publisher","unstructured":"Aghamohammadi A, Abolhassani H, Kutukculer N, Wassilak SG, Pallansch MA, Kluglein S et al. Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication. Front Immunol. 2017;8. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2017.00685\/full","DOI":"10.3389\/fimmu.2017.00685\/full"},{"key":"2628_CR5","unstructured":"WHO.Guidelines-for-Implementing-PID-Suveillance. 2022. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2022\/06\/Guidelines-for-Implementing-PID-Suveillance_EN.pdf"},{"key":"2628_CR6","doi-asserted-by":"publisher","unstructured":"Ben Salem I, Khemiri H, Drechsel O, Arbi M, B\u00f6ttcher S, Mekki N et al. Reversion of neurovirulent mutations, recombination and high intra-host diversity in vaccine-derived poliovirus excreted by patients with primary immune deficiency. J Med Virol. 2024;96(9):e29918. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/jmv.29918","DOI":"10.1002\/jmv.29918"},{"issue":"1","key":"2628_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/cimb45010003","volume":"45","author":"JV Garmendia","year":"2022","unstructured":"Garmendia JV, Garc\u00eda AH, De Sanctis CV, Hajd\u00fach M, De Sanctis JB. Autoimmunity and immunodeficiency in severe SARS-CoV-2 infection and prolonged COVID-19. Curr Issues Mol Biol. 2022;45(1):33\u201350. https:\/\/doi.org\/10.3390\/cimb45010003.","journal-title":"Curr Issues Mol Biol"},{"key":"2628_CR8","doi-asserted-by":"publisher","unstructured":"Dolan SA, Mulcahy Levy J, Moss A, Pearce K, Butler M, Jung S et al. SARS-CoV\u20102 persistence in immunocompromised children. Pediatr Blood Cancer.2021;68(12). Available at: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/pbc.29277","DOI":"10.1002\/pbc.29277"},{"issue":"8","key":"2628_CR9","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/s10875-021-01132-1","volume":"41","author":"MC Mohanty","year":"2021","unstructured":"Mohanty MC, Taur PD, Sawant UP, Yadav RM, Potdar V. Prolonged fecal shedding of SARS-CoV-2 in asymptomatic children with inborn errors of immunity. J Clin Immunol. 2021;41(8):1748\u201353. https:\/\/doi.org\/10.1007\/s10875-021-01132-1.","journal-title":"J Clin Immunol"},{"issue":"2","key":"2628_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10875-020-00928-x","volume":"41","author":"S Delavari","year":"2021","unstructured":"Delavari S, Abolhassani H, Abolnezhadian F, Babaha F, Iranparast S, Ahanchian H, et al. Impact of SARS-CoV-2 pandemic on patients with primary immunodeficiency. J Clin Immunol. 2021;41(2):345\u201355. https:\/\/doi.org\/10.1007\/s10875-020-00928-x.","journal-title":"J Clin Immunol"},{"issue":"9","key":"2628_CR11","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1017\/ice.2020.139","volume":"41","author":"N Rezaei","year":"2020","unstructured":"Rezaei N. COVID-19 affects healthy pediatricians more than pediatric patients. Infect Control Hosp Epidemiol. 2020;41(9):1106\u20137. https:\/\/doi.org\/10.1017\/ice.2020.139.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"2628_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jinf.2021.11.005","volume":"84","author":"H Chappell","year":"2022","unstructured":"Chappell H, Patel R, Driessens C, Tarr AW, Irving WL, Tighe PJ, et al. Immunocompromised children and young people are at no increased risk of severe COVID-19. J Infect. 2022;84(1):31\u20139. https:\/\/doi.org\/10.1016\/j.jinf.2021.11.005.","journal-title":"J Infect"},{"key":"2628_CR13","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Ram\u00f3n S, Berm\u00fadez A, Gonz\u00e1lez-Granado LI, Rodr\u00edguez-Gallego C, Sastre A, Soler-Palac\u00edn P et al. Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management. Front Immunol. 2019;10. Available at: https:\/\/www.frontiersin.org\/article\/https:\/\/doi.org\/10.3389\/fimmu.2019.00586","DOI":"10.3389\/fimmu.2019.00586"},{"key":"2628_CR14","doi-asserted-by":"publisher","first-page":"109097","DOI":"10.1016\/j.clim.2022.109097","volume":"243","author":"E Drzymalla","year":"2022","unstructured":"Drzymalla E, Green RF, Knuth M, Khoury MJ, Dotson WD, Gundlapalli A. COVID-19-related health outcomes in people with primary immunodeficiency: a systematic review. Clin Immunol Orlando Fla. 2022;243:109097. https:\/\/doi.org\/10.1016\/j.clim.2022.109097.","journal-title":"Clin Immunol Orlando Fla"},{"key":"2628_CR15","unstructured":"CDC. Healthcare Workers. Centers for Disease Control and Prevention. 2020. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/underlyingconditions.html. Accessed: January 14, 2023."},{"issue":"2","key":"2628_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jaci.2020.09.010","volume":"147","author":"I Meyts","year":"2021","unstructured":"Meyts I, Bucciol G, Quinti I, Neven B, Fischer A, Seoane E, et al. Coronavirus disease 2019 in patients with inborn errors of immunity: an international study. J Allergy Clin Immunol. 2021;147(2):520\u201331. https:\/\/doi.org\/10.1016\/j.jaci.2020.09.010.","journal-title":"J Allergy Clin Immunol"},{"key":"2628_CR17","unstructured":"Truong TT, Ryutov A, Pandey U, Yee R, Goldberg L, Bhojwani D, et al. Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity. MedRxiv Prepr Serv Health Sci. 2021. 2021.02.27.21252099."},{"issue":"6","key":"2628_CR18","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMsb2104756","volume":"385","author":"L Corey","year":"2021","unstructured":"Corey L, Beyrer C, Cohen MS, Michael NL, Bedford T, Rolland M. SARS-CoV-2 variants in patients with immunosuppression. N Engl J Med. 2021;385(6):562\u20136. https:\/\/doi.org\/10.1056\/NEJMsb2104756.","journal-title":"N Engl J Med"},{"issue":"1","key":"2628_CR19","doi-asserted-by":"publisher","first-page":"6405","DOI":"10.1038\/s41467-021-26602-3","volume":"12","author":"S Weigang","year":"2021","unstructured":"Weigang S, Fuchs J, Zimmer G, Schnepf D, Kern L, Beer J, et al. Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants. Nat Commun. 2021;12(1):6405. https:\/\/doi.org\/10.1038\/s41467-021-26602-3.","journal-title":"Nat Commun"},{"key":"2628_CR20","unstructured":"Raglow Z, Surie D, Chappell JD, Zhu Y, Martin ET, Kwon JH et al. SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis. Lancet Microbe. 2024;0(0). Available from: https:\/\/www.thelancet.com\/journals\/lanmic\/article\/PIIS2666-5247(23)00336-1\/fulltext"},{"issue":"4","key":"2628_CR21","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/jmv.27516","volume":"94","author":"L Wang","year":"2022","unstructured":"Wang L, Cheng G. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa. J Med Virol. 2022;94(4):1728\u201333. https:\/\/doi.org\/10.1002\/jmv.27516.","journal-title":"J Med Virol"},{"issue":"12","key":"2628_CR22","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3390\/jcm10122696","volume":"10","author":"J Dergham","year":"2021","unstructured":"Dergham J, Delerce J, Bedotto M, La Scola B, Moal V. Isolation of viable SARS-CoV-2 virus from feces of an immunocompromised patient suggesting a possible Fecal Mode of Transmission. J Clin Med. 2021;10(12):2696.","journal-title":"J Clin Med"},{"key":"2628_CR23","doi-asserted-by":"crossref","unstructured":"Mohanty MC, Taur PD, Sawant UP, Yadav RM, Potdar V. Prolonged Fecal Shedding of SARS-CoV-2 in Asymptomatic Children with Inborn Errors of Immunity. J Clin Immunol. 2021;41(8):1748\u201353. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8443305\/","DOI":"10.1007\/s10875-021-01132-1"},{"issue":"1","key":"2628_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1749-6632.2011.06379.x","volume":"1250","author":"S Al-Muhsen","year":"2012","unstructured":"Al-Muhsen S, Alsum Z. Primary immunodeficiency diseases in the Middle East. Ann N Y Acad Sci. 2012;1250(1):56\u201361. https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06379.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2628_CR25","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1186\/s12864-021-07870-1","volume":"22","author":"W Fares","year":"2021","unstructured":"Fares W, Chouikha A, Ghedira K, Gdoura M, Rezig D, Boubaker SH, et al. Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa. BMC Genomics. 2021;22(1):540. https:\/\/doi.org\/10.1186\/s12864-021-07870-1.","journal-title":"BMC Genomics"},{"issue":"3","key":"2628_CR26","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/v14030624","volume":"14","author":"A Chouikha","year":"2022","unstructured":"Chouikha A, Fares W, Laamari A, Haddad-Boubaker S, Belaiba Z, Ghedira K, et al. Molecular epidemiology of SARS-CoV-2 in Tunisia (North Africa) through several successive waves of COVID-19. Viruses mars. 2022;14(3):624. https:\/\/doi.org\/10.3390\/v14030624.","journal-title":"Viruses mars"},{"key":"2628_CR27","doi-asserted-by":"publisher","first-page":"990832","DOI":"10.3389\/fpubh.2022.990832","volume":"10","author":"S Haddad-Boubaker","year":"2023","unstructured":"Haddad-Boubaker S, Arbi M, Souiai O, Chouikha A, Fares W, Edington K, et al. The Delta variant wave in Tunisia: genetic diversity, spatio-temporal distribution and evidence of the spread of a divergent AY.122 sub-lineage. Front Public Health 4 janv. 2023;10:990832. https:\/\/doi.org\/10.3389\/fpubh.2022.990832.","journal-title":"Front Public Health 4 janv"},{"key":"2628_CR28","doi-asserted-by":"publisher","first-page":"1226207","DOI":"10.3389\/fmed.2023.1226207","volume":"10","author":"H Khemiri","year":"2023","unstructured":"Khemiri H, Gdoura M, Ben Halima S, Krichen H, Camm\u00e0 C, Lorusso A, et al. SARS-CoV-2 excretion kinetics in nasopharyngeal and stool samples from the pediatric population. Front Med. 2023;10:1226207. https:\/\/doi.org\/10.3389\/fmed.2023.1226207. PMID: 38020093; PMCID: PMC10643538.","journal-title":"Front Med"},{"key":"2628_CR29","doi-asserted-by":"crossref","unstructured":"Khemiri H, Mangone I, Gdoura M, Mefteh K, Chouikha A, Fares W et al. Dynamic of SARS-CoV-2 variants circulation in Tunisian pediatric population, during successive waves, from March 2020 to September 2022. Virus Res. 2024;344:199353. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168170224000467","DOI":"10.1016\/j.virusres.2024.199353"},{"issue":"5","key":"2628_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/v16050779","volume":"16","author":"A Borgi","year":"2024","unstructured":"Borgi A, Meftah K, Trabelsi I, Kyaw MH, Zaghden H, Bouafsoun A, et al. Retrospective analysis of clinical characteristics and Disease outcomes in children and adolescents hospitalized due to COVID-19 infection in Tunisia. Viruses. 2024;16(5):779. https:\/\/doi.org\/10.3390\/v16050779.","journal-title":"Viruses"},{"key":"2628_CR31","unstructured":"World health Organization. (2004). Manuel for virological Investigation of poliomyelitis, Geneva. https:\/\/iris.who.int\/handle\/10665\/68762 [Accessed 08\/05\/2023]."},{"key":"2628_CR32","unstructured":"World health Organization. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/peiris-protocol-16-1-20.pdf. [Accessed 08\/05\/2023]."},{"issue":"1","key":"2628_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12985-022-01784-4","volume":"19","author":"M Gdoura","year":"2022","unstructured":"Gdoura M, Abouda I, Mrad M, Ben Dhifallah I, Belaiba Z, Fares W, et al. SARS-CoV2 RT-PCR assays: in vitro comparison of 4 WHO approved protocols on clinical specimens and its implications for real laboratory practice through variant emergence. Virol J. 2022;19(1):54. https:\/\/doi.org\/10.1186\/s12985-022-01784-4.","journal-title":"Virol J"},{"issue":"11","key":"2628_CR34","doi-asserted-by":"publisher","first-page":"e21101","DOI":"10.1016\/j.heliyon.2023.e21101","volume":"9","author":"V Curini","year":"2023","unstructured":"Curini V, Ancora M, Jurisic L, Di Lollo V, Secondini B, Mincarelli LF, et al. Evaluation of next generation sequencing approaches for SARS-CoV-2. Heliyon. 2023;9(11):e21101. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21101.","journal-title":"Heliyon"},{"issue":"12","key":"2628_CR35","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3390\/vaccines10122134","volume":"10","author":"U Molini","year":"2022","unstructured":"Molini U, Coetzee LM, Engelbrecht T, de Villiers L, de Villiers M, Mangone I, Curini V, Khaiseb S, Ancora M, Camm\u00e0 C, Lorusso A, Franzo G. SARS-CoV-2 in Namibian dogs. Vaccines (Basel). 2022;10(12):2134. https:\/\/doi.org\/10.3390\/vaccines10122134. PMID: 36560544; PMCID: PMC9785506.","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"2628_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels PA, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A, et al. The nf-core framework for community-curated bioinformatics pipelines. Nat Biotechnol. 2020;38(3):276\u20138. https:\/\/doi.org\/10.1038\/s41587-020-0439-x.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"2628_CR37","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","volume":"5","author":"A Rambaut","year":"2020","unstructured":"Rambaut A, Holmes EC, O\u2019Toole \u00c1, Hill V, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020;5(11):1403\u20137. https:\/\/doi.org\/10.1038\/s41564-020-0770-5.","journal-title":"Nat Microbiol"},{"issue":"1","key":"2628_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/gch2.1018","volume":"1","author":"S Elbe","year":"2017","unstructured":"Elbe S, Buckland-Merrett G. Data, disease and diplomacy: GISAID\u2019s innovative contribution to global health. Glob Chall Hoboken NJ. 2017;1(1):33\u201346. https:\/\/doi.org\/10.1002\/gch2.1018.","journal-title":"Glob Chall Hoboken NJ"},{"issue":"8","key":"2628_CR39","doi-asserted-by":"publisher","first-page":"e28410","DOI":"10.1002\/pbc.28410","volume":"67","author":"A Ferrari","year":"2020","unstructured":"Ferrari A, Zecca M, Rizzari C, Porta F, Provenzi M, Marinoni M, et al. Children with cancer in the time of COVID-19: an 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy. Pediatr Blood Cancer. 2020;67(8):e28410. https:\/\/doi.org\/10.1002\/pbc.28410.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2628_CR40","doi-asserted-by":"publisher","first-page":"7003007","DOI":"10.21037\/apm-20-996","volume":"10","author":"L Wei","year":"2021","unstructured":"Wei L, Liu B, Zhao Y, Chen Z. Prolonged shedding of SARS-CoV-2 in an elderly liver transplant patient infected by COVID-19: a case report. Ann Palliat Med. 2021;10(6):7003007\u20137007. https:\/\/doi.org\/10.21037\/apm-20-996.","journal-title":"Ann Palliat Med"},{"issue":"4","key":"2628_CR41","doi-asserted-by":"publisher","first-page":"e0024421","DOI":"10.1128\/mSphere.00244-21","volume":"6","author":"V Borges","year":"2021","unstructured":"Borges V, Isidro J, Cunha M, Cochicho D, Martins L, Banha L, et al. Long-term evolution of SARS-CoV-2 in an immunocompromised patient with Non-hodgkin Lymphoma. mSphere. 2021;6(4):e0024421. https:\/\/doi.org\/10.1128\/mSphere.00244-21.","journal-title":"mSphere"},{"issue":"7","key":"2628_CR42","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","volume":"183","author":"VA Avanzato","year":"2020","unstructured":"Avanzato VA, Matson MJ, Seifert SN, Pryce R, Williamson BN, Anzick SL, et al. Case Study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic Immunocompromised Individual with Cancer. Cell. 2020;183(7):1901\u2013e19129. https:\/\/doi.org\/10.1016\/j.cell.2020.10.049.","journal-title":"Cell"},{"issue":"3","key":"2628_CR43","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jinf.2021.01.022","volume":"82","author":"JA Belsky","year":"2021","unstructured":"Belsky JA, Tullius BP, Lamb MG, Sayegh R, Stanek JR, Auletta JJ. COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients. J Infect. 2021;82(3):329\u201338. https:\/\/doi.org\/10.1016\/j.jinf.2021.01.022.","journal-title":"J Infect"},{"issue":"10","key":"2628_CR44","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1503\/cmaj.1011625","volume":"170","author":"CS L\u00e9ger","year":"2004","unstructured":"L\u00e9ger CS, Nevill TJ. Hematopoietic stem cell transplantation: a primer for the primary care physician. CMAJ Can Med Assoc J. 2004;170(10):1569\u201377. https:\/\/doi.org\/10.1503\/cmaj.1011625.","journal-title":"CMAJ Can Med Assoc J"},{"key":"2628_CR45","unstructured":"CDC. Centers for Disease Control and Prevention. 2020. Healthcare Workers. Available from: https:\/\/archive.cdc.gov\/www_cdc_gov\/coronavirus\/2019-ncov\/hcp\/duration-isolation.html0"},{"issue":"11","key":"2628_CR46","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3390\/v12111277","volume":"12","author":"J Calvet","year":"2020","unstructured":"Calvet J, Gratac\u00f3s J, Amengual MJ, Llop M, Navarro M, Moreno A, et al. CD4 and CD8 lymphocyte counts as surrogate early markers for progression in SARS-CoV-2 Pneumonia: a prospective study. Viruses. 2020;12(11):1277. https:\/\/doi.org\/10.3390\/v12111277.","journal-title":"Viruses"},{"issue":"2","key":"2628_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/v15020377","volume":"15","author":"R Villase\u00f1or-Echavarri","year":"2023","unstructured":"Villase\u00f1or-Echavarri R, Gomez-Romero L, Martin-Onraet A, Herrera LA, Escobar-Arrazola MA, Ramirez-Vega OA, et al. SARS-CoV-2 Genome variations in viral shedding of an immunocompromised patient with Non-hodgkin\u2019s lymphoma. Viruses. 2023;15(2):377. https:\/\/doi.org\/10.3390\/v15020377.","journal-title":"Viruses"},{"key":"2628_CR48","doi-asserted-by":"crossref","unstructured":"Alba JMG, P\u00e9rez-Mart\u00ednez Z, Boga JA, Rojo-Alba S, de O\u00f1a JG, Alvarez-Arg\u00fcelles ME et al. Emergence of New SARS-CoV2 Omicron Variants after the Change of Surveillance and Control Strategy. Microorganisms. 2022;10(10):1954. Available from: https:\/\/www.mdpi.com\/2076-2607\/10\/10\/1954","DOI":"10.3390\/microorganisms10101954"},{"key":"2628_CR49","doi-asserted-by":"crossref","unstructured":"Shikha S, Jogi MK, Jha R, Kumar RA, Sah T, Singh P et al. Genome sequencing of SARS-CoV-2 omicron variants in Delhi reveals alterations in immunogenic regions in spike glycoprotein. Front Immunol. 2023;14. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2023.1209513\/full","DOI":"10.3389\/fimmu.2023.1209513"},{"key":"2628_CR50","doi-asserted-by":"crossref","unstructured":"Scutari R, Fox V, Fini V, Granaglia A, Vittucci AC, Smarrazzo A et al. Molecular characterization of SARS-CoV-2 Omicron clade and clinical presentation in children. Sci Rep. 2024;14(1):5325. Available from: https:\/\/www.nature.com\/articles\/s41598-024-55599-0","DOI":"10.1038\/s41598-024-55599-0"},{"key":"2628_CR51","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ijid.2022.06.023","volume":"122","author":"EG Quaranta","year":"2022","unstructured":"Quaranta EG, Fusaro A, Giussani E, D\u2019Amico V, Varotto M, Pagliari M, et al. SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient. Int J Infect Dis IJID off Publ Int Soc Infect Dis. 2022;122:444\u20138. https:\/\/doi.org\/10.1016\/j.ijid.2022.06.023.","journal-title":"Int J Infect Dis IJID off Publ Int Soc Infect Dis"},{"key":"2628_CR52","unstructured":"Acharya B, Jamkhandikar S, Acharya B, Explainer, 417\u00a0N mutation? Reuters. What is the Delta variant of coronavirus with K. 2021; Available from: https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/what-is-delta-variant-coronavirus-with-k417n-mutation-2021-06-23\/"},{"issue":"3","key":"2628_CR53","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/07391102.2021.2014973","volume":"41","author":"M Kullappan","year":"2023","unstructured":"Kullappan M, Mary U, Ambrose JM, Veeraraghavan VP, Surapaneni KM. Elucidating the role of N440K mutation in SARS-CoV-2 spike - ACE-2 binding affinity and COVID-19 severity by virtual screening, molecular docking and dynamics approach. J Biomol Struct Dyn. 2023;41(3):912\u201329. https:\/\/doi.org\/10.1080\/07391102.2021.2014973.","journal-title":"J Biomol Struct Dyn"},{"key":"2628_CR54","doi-asserted-by":"crossref","unstructured":"Ntagereka PB, Oyola SO, Baenyi SP, Rono GK, Birindwa AB, Shukuru DW et al. Whole-genome sequencing of SARS-CoV-2 reveals diverse mutations in circulating Alpha and Delta variants during the first, second, and third waves of COVID-19 in South Kivu, east of the Democratic Republic of the Congo. Int J Infect Dis. 2022;122:136\u201343. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9119719\/","DOI":"10.1016\/j.ijid.2022.05.041"},{"key":"2628_CR55","doi-asserted-by":"crossref","unstructured":"Guruprasad K. Geographical Distribution of Amino Acid Mutations in Human SARS-CoV-2 Orf1ab Poly-Proteins Compared to the Equivalent Reference Proteins from China. ChemRxiv; 2020. Available from: https:\/\/chemrxiv.org\/engage\/chemrxiv\/article-details\/60c74fe20f50dbf22b3974b0","DOI":"10.26434\/chemrxiv.12951617"},{"key":"2628_CR56","doi-asserted-by":"publisher","unstructured":"Jha DK, Yashvardhini N, Kumar A, Sayrav K, Dinkar DK, Mutational, insight of ORF8 protein of SARS-CoV-2. Res J Life Sci Bioinforma Pharm Chem Sci. 2023;09(06). https:\/\/doi.org\/10.26479\/2023.0906.03.","DOI":"10.26479\/2023.0906.03"},{"key":"2628_CR57","doi-asserted-by":"crossref","unstructured":"Simas MCdaC, Costa SM, Gomes P, da SFC, Cruz NVG da, Corr\u00eaa IA, de Souza MRM et al. Evaluation of SARS-CoV-2 ORF7a Deletions from COVID-19-Positive Individuals and Its Impact on Virus Spread in Cell Culture. Viruses. 2023;15(3):801. Available from: https:\/\/www.mdpi.com\/1999-4915\/15\/3\/801","DOI":"10.3390\/v15030801"},{"key":"2628_CR58","doi-asserted-by":"publisher","unstructured":"Pulakuntla S, Lokhande KB, Padmavathi P, Pal M, Swamy KV, Sadasivam J et al. Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach. VirusDisease. 2021;32(4):690\u2013702. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8282177\/. https:\/\/doi.org\/10.1007\/s13337-021-00720-4","DOI":"10.1007\/s13337-021-00720-4"},{"key":"2628_CR59","doi-asserted-by":"crossref","unstructured":"Al Yazidi LS, Al Rawahi H, Al Busaidi I, Al Tamemi S. COVID-19 and primary immunodeficiency: one\u2010year experience. J Paediatr Child Health. 2021;57(4):594\u2013594. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jpc.15433","DOI":"10.1111\/jpc.15433"},{"key":"2628_CR60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-med-052422-020316","volume":"75","author":"HS Andrews","year":"2024","unstructured":"Andrews HS, Herman JD, Gandhi RT. Treatments for COVID-19. Annu Rev Med. 2024;75:145\u201357. https:\/\/doi.org\/10.1146\/annurev-med-052422-020316.","journal-title":"Annu Rev Med"},{"key":"2628_CR61","unstructured":"NIH. 2023. Coronavirus disease 2019 (COVID-19) treatment guidelines. Natl. Inst. Health. http:\/\/www.covid19treatmentguidelines.nih.gov"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02628-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02628-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T23:07:57Z","timestamp":1736809677000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02628-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2628"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02628-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involving human subjects was approved by the Bio-Medical Ethics Committee of Pasteur Institute of Tunis, Tunisia (2020\/14\/I\/LR16IPT\/V1). It was conducted in accordance with local legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for the collection of samples and data specifically for this study was obtained from the parents or legal tutor of children.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}